Enlivex Therapeutics Ltd
NASDAQ:ENLV

Watchlist Manager
Enlivex Therapeutics Ltd Logo
Enlivex Therapeutics Ltd
NASDAQ:ENLV
Watchlist
Price: 1.41 USD 0.71% Market Closed
Updated: May 18, 2024

Enlivex Therapeutics Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Enlivex Therapeutics Ltd
Interest Income Expense Peer Comparison

Comparables:
CLGN
KMDA
URGN
ENTX
B
BONS

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Enlivex Therapeutics Ltd
NASDAQ:ENLV
Interest Income Expense
$341k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Interest Income Expense
$503k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Interest Income Expense
-$85k
CAGR 3-Years
58%
CAGR 5-Years
N/A
CAGR 10-Years
30%
Urogen Pharma Ltd
NASDAQ:URGN
Interest Income Expense
-$9.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Interest Income Expense
$31k
CAGR 3-Years
N/A
CAGR 5-Years
-43%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Interest Income Expense
₪1.3m
CAGR 3-Years
N/A
CAGR 5-Years
74%
CAGR 10-Years
N/A

See Also

What is Enlivex Therapeutics Ltd's Interest Income Expense?
Interest Income Expense
341k USD

Based on the financial report for Dec 31, 2023, Enlivex Therapeutics Ltd's Interest Income Expense amounts to 341k USD.